Montreal, QC - Pioglitazone (Actos, Takeda) is associated with an increased risk of incident bladder cancer among those with type 2 diabetes, according to the results of a nested case-control study ...

March 9, 2007 — Pioglitazone therapy may be linked to an increased risk for fracture in women, warns the US Food and Drug Administration (FDA) and Takeda. The warning is based on data from the company ...

Please provide your email address to receive an email when new articles are posted on . Both 15 mg and 30 mg pioglitazone doses have similar efficacy as 45 mg for preventing new-onset diabetes, stroke ...

Indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes (non-insulin dependent diabetes mellitus, NIDDM). Pioglitazone HCl is indicated for ...

The results will not wipe out a recent $2.37 billion settlement reached in about 9000 bladder cancer claims involving the drug. A large-scale study published today in JAMA found that that use of ...

Please provide your email address to receive an email when new articles are posted on . Pioglitazone and SGLT2 inhibitors as add-ons to insulin therapy were more effective for lowing HbA1c, fasting ...

Learn everything you need to know about Pioglitazone-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, ...

The FDA has released an updated safety announcement following a fresh review of data on the type 2 diabetes treatment pioglitazon to confirm that the drug may increase a person’s likelihood of ...

In a recent issue of JAMA, Lewis et al. present long-term data on the likelihood of a link between pioglitazone and the risk of bladder cancer and ten other cancers. Their findings contradict previous ...

HONOLULU, HI—Patients with a prior stroke or TIA who have prediabetes detected using widely available clinical assessments seem to derive a benefit from pioglitazone, post hoc analysis of the IRIS ...